Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies

Diabetes

Volumn 48, Issue 1, 1999, Pages 150-157

  Tuomi, Tiinamaija ^a   Carlsson, ÅsaLinda ^a   Li, Haiyan ^a   Isomaa, Bo ^b   Miettinen, Aaro ^c   Nilsson, Anita ^a   Nissén, Michael ^e   Ehrnström, Björn Olof ^d   Forsén, Björn ^d   Snickars, Börje ^d   Lahti, Kaj ^d   Forsblom, Carol ^c   Saloranta, Carola ^c   Taskinen, Marja Riitta ^c   Groop, Leif C ^a  

^a LUND UNIVERSITY   (Sweden)

^b Jakobstad Hospital   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Primary Health Care Center   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GAD ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DQ ANTIGEN; INSULIN; INSULIN ANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; FINLAND; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ALLELES; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE INTOLERANCE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES;

EID: 0032955251     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.1.150     Document Type: Article

References (46)

1. Irvine WJ, Gray RS, McCallum CJ, Duncan LJP: Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycemic agents. Lancet i:1025-1037, 1977
2. Groop L, Bottazzo GF, Doniach D: Islent cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
3. Landin-Olsson M, Nilsson KO, Lernmark Å, Sundkvist G: Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568, 1990
4. Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark Å, Sundkvist G: Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902-910, 1993
5. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
6. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark Å: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
7. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R, for UK Prospective Diabetes Study (UKPDS) Group: UKPDS 25: autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
8. Groop L, Miettinen A, Groop P, Meri S, Koskimies S, Bottazzo G: Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 37:99-103, 1988
9. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang A: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
10. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 18:1557-1565, 1995
11. Abiru N, Takino H, Yano M, Kawasaki E, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S: Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. J Autoimmun 9:683-688, 1996
12. Fukui M, Nakano K, Shigeta H, Yoshimori K, Fujii M, Kitagawa Y, Mori H, Kajiyama S, Nakamura N, Abe N, Obayashi H, Fukui I, Ohta K, Ohta M, Kondo M: Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy. Diabet Med 14:148-152, 1997
13. Alberti KGMM, Zimmet PZ, Consultation W: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
14. Gottsäter A, Afmed M, Lilja B, Fernlund P, Sundkvist G: Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM. Diabetes Care 19:60-63, 1996
15. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
16. Field LL, Tobias R, Magnus T: A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet 8:189-194, 1994
17. Zamani M, Pociot F, Raeymaekers P, Nerup J, Cassiman JJ: Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Hum Genet 98:491-496, 1996
18. Hashimoto L, Habita C, Beressi J, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161-164, 1994
19. Davies JL, Cucca F, Goy JV, Atta ZAA, Merriman ME, Wilson A, Barnett AH, Bain SC, Todd JA: Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes. Hum Mol Gen 5:1071-1074, 1996
20. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Rønningen KS, Undlien DE, Nisticò L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornélis F, Barnett AH, Bain SC, Todd JA: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 9:80-85, 1995
21. Owerbach D, Gabbay KH: The HOXD8 locus (2q31) is linked to type I diabetes: interaction with chromosome 6 and 11 disease susceptibility genes. Diabetes 44:132-136, 1995
22. Luo DF, Maclaren NK, Huang HS, Muir A, She JX: Intrafamilial and case-control association analysis of D2S152 in insulin-dependent diabetes. Autoimmunity 21:143-147, 1995
23. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Serrano Rios M, Chow CC, Cockram CS, Jacobs K, Mijovic C, Boin SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Belgian Diabetes Registry, Tosi R, Pozzilli P, Todd JA: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Gen 5:1075-1080, 1996
24. Groop L, Groop PH, Koskimies S: Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 29:757-760, 1986
25. Rich SS, French LR, Sprafka JM, Clements JP, Goetz FC: HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study. Diabetologia 36:234-238, 1993
26. Tuomilehto Wolf E, Tuomilehto J, Hitman GA, Nissinan A, Stengard J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen MJ.: Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 307:155-159, 1993
27. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
28. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
29. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullström M, Isomaa B, Lehtovirta M, Hyrkkö A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen M, Groop L: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997
30. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Häggblom M, Groop L: Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467-473, 1998
31. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian W, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
32. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark Å: Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19:113-125, 1994
33. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS, and participating laboratories: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47: 1857-1866, 1998
34. Miettinen A, Holthöfer H, Kontiainen S, Miettinen M, Andersson LC: Antibodies against gastrointestinal carcinoid tumors in IDDM. Diabetes 38:667-669, 1989
35. Heding LG: Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548, 1975
36. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Tsuji K, Aizawa M, Sasazuki T, Eds. Oxford, U.K., Oxford University Press, 1993, p. 391-419
37. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Rønningen KS, Barnett AH, Bain SC, Todd JA: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9:284-292, 1995
38. Ilonen J, Reijonen H, Herva E, Sjöroos M, Iitiä A, Lövgren T, Veijola R, Knip M, Åkerblom HK: Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population: the Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 19:795-800, 1996
39. Bell GI, Horita S, Karam JH: A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33:176-183, 1984
40. Metcalfe KA, Hitman GA, Fennessy MJ, McCarthy MI, Tuomilehto J, Tuomilehto Wolf E: In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk: DiMe (Childhood Diabetes in Finland) Study Group. Diabetologia 38:1223-1229, 1995
41. Halminen M, Veijola R, Reijonen H, Ilonen J, Akerblom HK, Knip M: Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion: the Childhood Diabetes in Finland (DiMe) Study Group. Eur J Clin Invest 26:847-852, 1996
42. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years: the Belgian Diabetes Registry. Diabetologia 36:1155-1162, 1993
43. Mustonen A, Ilonen J, Tiilikainen A, Kataja M, Åkerblom HK: An analysis of epidemiological data in HLA-typed diabetic children. Diabetologia 28:397-400, 1985
44. Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving H, Deckert T, Mølsted-Pedersen L, Kühl C, Buschard K, Green A: HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28:237-244, 1986
45. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M: A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 320:881-886, 1989
46. Lohmann T, Seissler J, Verlohren H, Schröder A, Rötger J, Dähn K, Morgenthaler N, Scherbaum WA: Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20:524-529, 1997